New York Times CENTER-LEFT (-1.0) Reliability: 8.0/10

Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs

✍️ Dani Blum, Rebecca Robbins 📅 November 14, 2025 12:00 AM 🕐 Scraped: November 14, 2025

Summary: The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.

Last week, Robert F. Kennedy Jr., the nation’s health secretary, stood in the Oval Office and lauded President Trump’s new drug pricing deal for weight loss drugs

📰

Continue Reading on New York Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Dani Blum, Rebecca Robbins

Original Publisher

🌍 New York Times

CENTER-LEFT Bias (-1.0)

Published Date

November 14, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only